OSELTAMIVIR and OFF LABEL USE

Overview

OFF LABEL USE is the #1 most commonly reported adverse reaction for OSELTAMIVIR, manufactured by Amneal Pharmaceuticals NY LLC. There are 1,776 FDA adverse event reports linking OSELTAMIVIR to OFF LABEL USE. This represents approximately 9.3% of all 19,111 adverse event reports for this drug.

Patients taking OSELTAMIVIR who experience off label use should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

OFF LABEL USE1,776 of 19,111 reports

OFF LABEL USE is moderately reported among OSELTAMIVIR users, representing a notable but not dominant share of adverse events.

Other Side Effects of OSELTAMIVIR

In addition to off label use, the following adverse reactions have been reported for OSELTAMIVIR:

DRUG INEFFECTIVE — 713 reports
NO ADVERSE EVENT — 582 reports
VOMITING — 444 reports
NAUSEA — 443 reports
HEADACHE — 381 reports
PNEUMONIA — 368 reports
CONDITION AGGRAVATED — 333 reports
INFLUENZA — 329 reports
PRODUCT USE IN UNAPPROVED INDICATION — 328 reports
DRUG INTOLERANCE — 325 reports

Other Drugs Associated with OFF LABEL USE

The following drugs have also been linked to off label use in FDA adverse event reports:

0XYGEN ABACAVIR SULFATE ABATACEPT ABIRATERONE ACETATE ACALABRUTINIB ACETAMINOPHEN ACETAMINOPHEN 500MG ACETAMINOPHEN AND CODEINE ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE ACETAMINOPHEN AND IBUPROFEN ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, ASPIRIN, AND CAFFEINE ACETAMINOPHEN, ASPIRIN, CAFFEINE ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE ACETAMINOPHEN, CAFFEINE ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, IBUPROFEN

Does OSELTAMIVIR cause OFF LABEL USE?

OFF LABEL USE has been reported as an adverse event in 1,776 FDA reports for OSELTAMIVIR. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is OFF LABEL USE with OSELTAMIVIR?

OFF LABEL USE accounts for approximately 9.3% of all adverse event reports for OSELTAMIVIR, making it one of the most commonly reported side effect.

What should I do if I experience OFF LABEL USE while taking OSELTAMIVIR?

If you experience off label use while taking OSELTAMIVIR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.